Politicians have been talking for years about reducing prescription drug prices, and the talk stands a good chance of becoming reality with the passage of the federal Inflation Reduction Act.
The process is gradual, affecting a limited list of drugs at first, then expanding over the next seven years. The Oregon State Pharmacy Association, a trade group, has been analyzing the drug price provisions of the IRA.
A rep from the group visits to talk about potential impacts in the near and long term for Oregon consumers.